|
US2014072644A1
|
|
Anti-misuse microparticulate oral pharmaceutical form
|
|
FR2999426A1
|
|
MULTIPARTICULAR ORAL FORM WITH IMMEDIATE RELEASE OF AT LEAST ONE ACTIVE COMPOUND, INCLUDING MILL RESISTANT MIXED PARTICLES.
|
|
FR2975912A1
|
|
CONTROLLED RELEASE COMPOSITION OF BUPRENORPHINE
|
|
FR2975301A1
|
|
COMPOSITION COMPRISING AN ALPHA INTERFERON
|
|
US2011150837A1
|
|
Amphiphilic polymer functionalized by methionine
|
|
FR2968994A1
|
|
PROCESS FOR THE PREPARATION OF NANOPARTICLES
|
|
FR2968993A1
|
|
NANOPARTICLES COMPRISING AT LEAST ONE ACTIVE AND AT LEAST TWO POLYELECTROLYTES
|
|
FR2954325A1
|
|
AMPHIPHILIC POLYMER FUNCTIONALIZED BY METHIONINE
|
|
FR2952936A1
|
|
ACRYLIC OR METHACRYLIC TYPE POLYMER COMPRISING ALPHA-TOCOPHEROL GRAFT
|
|
FR2951378A1
|
|
ANTI-MEASURING SOLID ORAL PHARMACEUTICAL FORM WITH A SPECIFIC MODIFIED RELEASE PROFILE
|
|
FR2945945A1
|
|
PROCESS FOR PREPARING HOLLOW PARTICLES AND THEIR APPLICATIONS
|
|
FR2945947A1
|
|
FLOATING PHARMACEUTICAL COMPOSITIONS WITH CONTROLLED RELEASE
|
|
FR2934161A1
|
|
MICROPARTICULAR ORAL FORM USEFUL FOR THE MODIFIED RELEASE OF NANOPARTICLES.
|
|
FR2930147A1
|
|
SOLID ORAL FORM WITH A DOUBLE RELEASE PROFILE
|
|
FR2915684A1
|
|
PARTICLES BASED ON POLYELECTROLYTES AND MODIFIED RELEASE ACTIVE INGREDIENTS AND PHARMACEUTICAL FORMULATIONS CONTAINING THESE PARTICLES
|
|
FR2915748A1
|
|
POLYGLUTAMIC ACIDS FUNCTIONALIZED BY CATIONIC GROUPS AND HYDROPHOBIC GROUPS AND THEIR APPLICATIONS, IN PARTICULAR THERAPEUTIC
|
|
US2007264346A1
|
|
Multimicroparticulate pharmaceutical forms for oral administration
|
|
US2007173464A1
|
|
Oral ribavirin pharmaceutical compositions
|
|
FR2904219A1
|
|
AMPHIPHILIC COPOLYMER-BASED MICROPARTICLES AND MODIFIED RELEASE ACTIVE INGREDIENT (S) AND PHARMACEUTICAL FORMULATIONS CONTAINING SAME
|
|
FR2902007A1
|
|
PHARMACEUTICAL FORMULATIONS FOR PROLONGED DELIVERY OF ACTIVE (S) PRINCIPLE (S) AND THEIR PARTICULARLY THERAPEUTIC APPLICATIONS
|
